HIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Genome-wide siRNA screens have identified host cell factors important for efficient HIV infection, among which are nuclear pore proteins such as RanBP2/Nup358 and the karyopherin Transportin-3/TNPO3. Analysis of the roles of these proteins in the HIV replication cycle suggested that correct trafficking through the pore may facilitate the subsequent integration step. Here we present data for coupling between these steps by demonstrating that depletion of Transportin-3 or RanBP2 altered the terminal step in early HIV replication, the selection of chromosomal sites for integration. We found that depletion of Transportin-3 and RanBP2 altered integration targeting for HIV. These knockdowns reduced HIV integration frequency in gene-dense regions and near gene-associated features, a pattern that differed from that reported for depletion of the HIV integrase binding cofactor Psip1/Ledgf/p75. MLV integration was not affected by the Transportin-3 knockdown. Using siRNA knockdowns and integration targeting analysis, we also implicated several additional nuclear proteins in proper target site selection. To map viral determinants of integration targeting, we analyzed a chimeric HIV derivative containing MLV gag, and found that the gag replacement phenocopied the Transportin-3 and RanBP2 knockdowns. Thus, our data support a model in which Gag-dependent engagement of the proper transport and nuclear pore machinery mediate trafficking of HIV complexes to sites of integration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Effects of Transportin-3 and RanBP2 depletion on integration near multiple chromosomal features. Genes targeted by siRNA in infected cells including the control, GL2, are shown above the columns. Mock cells received no siRNA. The genomic features analyzed are shown in the rows and labeled on the left. Relationships between integration frequency and feature density are summarized using ROC curve areas [18], where increasing shades of blue indicate a negative correlation with integration frequency and increasing shades of red indicate a positive correlation with integration frequency relative to matched random control distributions. The control GL2 siRNA set was used for pairwise statistical comparisons (overlay dashes). P values summarizing the significance of the departure from the GL2 control are shown with asterisks (*P<0.05; **P<0.01; ***P<0.001). Note that the asterisks and the heat map summarize different comparisons (to siGL2 and matched random controls, respectively). The base pair values in the row labels indicate the size of the genomic interval used for analysis–often the most appropriate interval is not known, so several different interval sizes are compared. A more detailed guide to the data presented in this figure can be found in Text S1. An interactive version of this figure is available as Figure S5.](https://figures.cochat.ai/paper-figures/b86a468bc0314fbf9ec12b4991cdda2b/hiv-integration-targeting-a-pathway-involving-transportin-3-and-the-nuclear-pore-figure-2.jpg)






![Figure 9 Model for coupling of nuclear import and integration targeting. Interaction with Transportin-3 and RanBP2 shuttles the PIC through the nuclear pore and toward gene dense regions favored for HIV integration. Interactions with additional factors in the nucleus (ANAPC2, WDH1, IK, PRPF38A, and SNW1) may also play a role in site selection upstream of the known integration cofactor Ledgf/p75, which targets integration to active transcription units. RNA Pol indicates RNA polymerase II, which is known to be required for transcriptional activity, and which promotes integration [13]–[15], [18]. Nucleosomes are shown because target DNA is known to be wrapped in nucleosomes during the integration step [36], [57]–[60]. PIC, preintegration complex; FG, phenylalanine-glycine repeat sequences of nuclear pore proteins.](https://figures.cochat.ai/paper-figures/8bfb1b515cab48e1acda8e401d271b5e/hiv-integration-targeting-a-pathway-involving-transportin-3-and-the-nuclear-pore-figure-9.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depletion of cellular Nup153 or Nup358 also shifted HIV-1 integration away from gene-dense regions of chromatin88,89”
From Structure and function of retroviral integrase (2022) · cites this paper as [89]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903 · cited 1×
“VSV-G pseudotyped HIV vector particles were produced in HEK 293T cells by Lipofectamine (Invitrogen, Carlsbad CA) transfection of p156RRLsin-PPTCMVGFPWPRE [52], the packaging construct pCMVdeltaR9 [53], and the vesicular stomatitis virus G-producing plasmid pMD.”
MethodHIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Self-citationIdentification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449 · cited 1×
“Passage through the pore is likely a preferred route of nuclear entry for HIV-1 even in dividing cells – several components of the nuclear pore are required for efficient infection of dividing cells, even though PICs might access the nucleus during nuclear breakdown in mitosis”
BackgroundSimonis, M., Klous, P., Splinter, E., Moshkin, Y., Willemsen, R., de Wit, E., van Steensel, B., & de Laat, W. (2006) · Nature Genetics · doi:10.1038/ng1896 · Cited by 1,386 · cited 1×
“Several studies suggest that chromosomes and genes are nonrandomly distributed in the nucleus, though the organization is not fully clarified [42–44].”
BackgroundTranscription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305 · cited 3×
“show a preference for integration near gene 59 ends and CpG islands [13–15].”
BackgroundInfluentialActive genes dynamically colocalize to shared sites of ongoing transcription
Osborne, C. S., Chakalova, L., Brown, K. E., Carter, D., Horton, A., Debrand, E., Goyenechea, B., Mitchell, J. A., Lopes, S., Reik, W., et al. (2004) · Nature Genetics · doi:10.1038/ng1423 · Cited by 1,056
Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences
Mitchell, R. S., Beitzel, B. F., Schroder, A. R. W., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020234 · Cited by 976
Self-citationGlobal Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication
König, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M. C., Irelan, J. T., Chiang, C.-Y., Tu, B. P., De Jesus, P. D., Lilley, C. E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.032 · Cited by 960
Self-citation
Cited by
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Fraietta, J. A., Nobles, C. L., Sammons, M. A., Lundh, S., Carty, S. A., Reich, T. J., Cogdill, A. P., Morrissette, J. J. D., DeNizio, J. E., Reddy, S., et al. (2018) · Nature · doi:10.1038/s41586-018-0178-z · Cited by 862
Self-citationDecade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
Scholler, J., Brady, T. L., Binder-Scholl, G., Hwang, W.-T., Plesa, G., Hege, K. M., Vogel, A. N., Kalos, M., Riley, J. L., Deeks, S. G., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003761 · Cited by 652
Self-citationSchaller, T., Ocwieja, K. E., Rasaiyaah, J., Price, A. J., Brady, T. L., Roth, S. L., Hué, S., Fletcher, A. J., Lee, K., KewalRamani, V. N., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002439 · Cited by 470
“We have shown that Nup358 or TRN-SR2 depletion reduces HIV-1 integration frequency near these features [16].”
BackgroundMethodResultInfluentialSelf-citationHIV-1 evades innate immune recognition through specific cofactor recruitment
Rasaiyaah, J., Tan, C. P., Fletcher, A. J., Price, A. J., Blondeau, C., Hilditch, L., Jacques, D. A., Selwood, D. L., James, L. C., Noursadeghi, M., et al. (2013) · Nature · doi:10.1038/nature12769 · Cited by 458
Self-citationThe hidden burden of influenza: A review of the extra‐pulmonary complications of influenza infection
Sellers, S. A., Hagan, R. S., Hayden, F. G., & Fischer, W. A. (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12470 · Cited by 438
HIV-1 capsid: the multifaceted key player in HIV-1 infection
Campbell, E. M., & Hope, T. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3503 · Cited by 430
HIV-1 transcription and latency: an update
Van Lint, C., Bouchat, S., & Marcello, A. (2013) · Retrovirology · doi:10.1186/1742-4690-10-67 · Cited by 338
HIV-1 uncoats in the nucleus near sites of integration
Burdick, R. C., Li, C., Munshi, M., Rawson, J. M. O., Nagashima, K., Hu, W.-S., & Pathak, V. K. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920631117 · Cited by 313
Price, A. J., Jacques, D. A., McEwan, W. A., Fletcher, A. J., Essig, S., Chin, J. W., Halambage, U. D., Aiken, C., & James, L. C. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004459 · Cited by 284
“We mutated these residues and tested their sensitivity to restriction by CPSF6DNLS and TRIM-NUP153 and their dependence on TNPO3.”
BackgroundInfluentialSelf-citationMatreyek, K. A., Yücel, S. S., Li, X., & Engelman, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003693 · Cited by 280
CPSF6 Defines a Conserved Capsid Interface that Modulates HIV-1 Replication
Price, A. J., Fletcher, A. J., Schaller, T., Elliott, T., Lee, K., KewalRamani, V. N., Chin, J. W., Towers, G. J., & James, L. C. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002896 · Cited by 264
Self-citationSowd, G. A., Serrao, E., Wang, H., Wang, W., Fadel, H. J., Poeschla, E. M., & Engelman, A. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524213113 · Cited by 249
“Although knockdown of NUP153 (14, 17) or NUP358 (18) significantly reduced integration into genes and gene-dense regions, gene-tropic integration nevertheless remained significantly enriched over random under these conditions.”
BackgroundInfluentialLesbats, P., Engelman, A. N., & Cherepanov, P. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00125 · Cited by 233
Capsid-CPSF6 Interaction Licenses Nuclear HIV-1 Trafficking to Sites of Viral DNA Integration
Achuthan, V., Perreira, J. M., Sowd, G. A., Puray-Chavez, M., McDougall, W. M., Paulucci-Holthauzen, A., Wu, X., Fadel, H. J., Poeschla, E. M., Multani, A. S., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.08.002 · Cited by 205
“, 2014) and other import cofactors, including transportin 3 (TNPO3), nucleoporin (NUP) 358 (Ocwieja et al., 2011), cyclophilin A (Schaller et al.”
BackgroundInfluentialHindmarsh, P., & Leis, J. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.4.836-843.1999 · Cited by 202
Nuclear landscape of HIV-1 infection and integration
Lušić, M., & Siliciano, R. F. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.162 · Cited by 201
BET proteins promote efficient murine leukemia virus integration at transcription start sites
Sharma, A., Larue, R. C., Plumb, M. R., Malani, N., Male, F., Slaughter, A., Kessl, J. J., Shkriabai, N., Coward, E., Aiyer, S. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307157110 · Cited by 193
“To delineate the Brd3(1-726) segments (Fig.”
BackgroundResultInfluentialSelf-citationHuman Nucleoporins Promote HIV-1 Docking at the Nuclear Pore, Nuclear Import and Integration
Di Nunzio, F., Danckaert, A., Fricke, T., Perez, P., Fernandez, J., Perret, E., Roux, P., Shorte, S., Charneau, P., Diaz-Griffero, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046037 · Cited by 192
Matreyek, K., & Engelman, A. (2013) · Viruses · doi:10.3390/v5102483 · Cited by 145
Biosafety Features of Lentiviral Vectors
Schambach, A., Zychlinski, D., Ehrnstroem, B., & Baum, C. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.229 · Cited by 173
“…mechanisms: the function of the cellular protein LEDGF/p75 as a tethering factor of the integrase, and the ‘‘injection’’ of the PIC through nuclear baskets, thus preferentially targeting genomic regions of active chromatin located next to these sites (Ocwieja et al., 2011; Schaller et al., 2011).”
Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication
Di Nunzio, F., Fricke, T., Miccio, A., Valle-Casuso, J. C., Perez, P., Souque, P., Rizzi, E., Severgnini, M., Mavilio, F., Charneau, P., et al. (2013) · Virology · doi:10.1016/j.virol.2013.02.008 · Cited by 170
IP6 is an HIV pocket factor that prevents capsid collapse and promotes DNA synthesis
Mallery, D. L., Márquez, C. L., McEwan, W. A., Dickson, C. F., Jacques, D. A., Anandapadamanaban, M., Bichel, K., Towers, G. J., Saiardi, A., Böcking, T., et al. (2018) · eLife · doi:10.7554/elife.35335 · Cited by 170
Self-citationMolecular mechanisms of retroviral integration site selection
Kvaratskhelia, M., Sharma, A., Larue, R. C., Serrao, E., & Engelman, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku769 · Cited by 135
The Host Proteins Transportin SR2/TNPO3 and Cyclophilin A Exert Opposing Effects on HIV-1 Uncoating
Shah, V. B., Shi, J., Hout, D. R., Oztop, I., Krishnan, L., Ahn, J., Shotwell, M. S., Engelman, A., & Aiken, C. (2013) · Journal of Virology · doi:10.1128/jvi.07177-11 · Cited by 126
Mechanisms of Retroviral Integration and Mutagenesis
Cavazza, A., Moiani, A., & Mavilio, F. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.203 · Cited by 125
Structure, Function, and Interactions of the HIV-1 Capsid Protein
Rossi, E., Meuser, M. E., Cunanan, C. J., & Cocklin, S. (2021) · Life · doi:10.3390/life11020100 · Cited by 141
Capsid-Dependent Host Factors in HIV-1 Infection
Yamashita, M., & Engelman, A. N. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.04.004 · Cited by 122
Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration
Zhou, L., Sokolskaja, E., Jolly, C., James, W., Cowley, S. A., & Fassati, A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002194 · Cited by 130
“Our model is supported by recent evidence indicating that depletion of Tnp3 results in an aberrant pattern of HIV-1 integration [72].”
Nobles, C. L., Sherrill-Mix, S., Everett, J. K., Reddy, S., Fraietta, J. A., Porter, D. L., Frey, N., Gill, S. I., Grupp, S. A., Maude, S. L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130144 · Cited by 130
Self-citationMichaud, V., Bar-Magen, T., Turgeon, J., Flockhart, D. A., Desta, Z., & Wainberg, M. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005553 · Cited by 130
Key Viral Adaptations Preceding the AIDS Pandemic
Sauter, D., & Kirchhoff, F. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2018.12.002 · Cited by 130
HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358
Bichel, K., Price, A. J., Schaller, T., Towers, G. J., Freund, S. M., & James, L. C. (2013) · Retrovirology · doi:10.1186/1742-4690-10-81 · Cited by 114
Self-citationNuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2
Kane, M., Rebensburg, S. V., Takata, M. A., Zang, T. M., Yamashita, M., Kvaratskhelia, M., & Bieniasz, P. D. (2018) · eLife · doi:10.7554/elife.35738 · Cited by 120
Structure and function of retroviral integrase
Maertens, G. N., Engelman, A. N., & Cherepanov, P. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00586-9 · Cited by 124
A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase
Sharma, A., Slaughter, A., Jena, N., Feng, L., Kessl, J. J., Fadel, H. J., Malani, N., Male, F., Wu, L., Poeschla, E., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004171 · Cited by 124
“Isolation of integration sites using 454-pyrosequencing Isolation of HIV-1 integration sites was performed using ligation-mediated PCR as previously described [75,76] with some changes.”
MethodSelf-citationSpatially clustered loci with multiple enhancers are frequent targets of HIV-1 integration
Lucic, B., Chen, H.-C., Kuzman, M., Zorita, E., Wegner, J., Minneker, V., Wang, W., Fronza, R., Laufs, S., Schmidt, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12046-3 · Cited by 107
Koh, Y., Wu, X., Ferris, A. L., Matreyek, K. A., Smith, S. J., Lee, K., KewalRamani, V. N., Hughes, S. H., & Engelman, A. (2013) · Journal of Virology · doi:10.1128/jvi.01148-12 · Cited by 122
Multiple roles of the capsid protein in the early steps of HIV-1 infection
Fassati, A. (2012) · Virus Research · doi:10.1016/j.virusres.2012.09.012 · Cited by 122
Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases
Poletti, V., & Mavilio, F. (2021) · Viruses · doi:10.3390/v13081526 · Cited by 120
HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection
Bangham, C. R. M., Cook, L. B., & Melamed, A. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.11.003 · Cited by 105
HIV-1 Maturation: Lessons Learned from Inhibitors
Kleinpeter, A. B., & Freed, E. O. (2020) · Viruses · doi:10.3390/v12090940 · Cited by 119
Ritterhoff, T., Das, H., Hofhaus, G., Schröder, R. R., Flotho, A., & Melchior, F. (2016) · Nature Communications · doi:10.1038/ncomms11482 · Cited by 117
Transportin-1 binds to the HIV-1 capsid via a nuclear localization signal and triggers uncoating
Fernandez, J., Machado, A. K., Lyonnais, S., Chamontin, C., Gärtner, K., Léger, T., Henriquet, C., Garcia, C., Portilho, D. M., Pugnière, M., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0575-6 · Cited by 116
Epigenetic control of HIV-1 post integration latency: implications for therapy
Kumar, A., Darcis, G., Lint, C. M. V., & Herbein, G. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0137-6 · Cited by 115
Host and viral determinants for MxB restriction of HIV-1 infection
Matreyek, K. A., Wang, W., Serrao, E., Singh, P. K., Levin, H. L., & Engelman, A. (2014) · Retrovirology · doi:10.1186/s12977-014-0090-z · Cited by 103
A model for cofactor use during HIV-1 reverse transcription and nuclear entry
Hilditch, L., & Towers, G. J. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.11.003 · Cited by 91
Self-citationVranckx, L. S., Demeulemeester, J., Saleh, S., Boll, A., Vansant, G., Schrijvers, R., Weydert, C., Battivelli, E., Verdin, E., Cereseto, A., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.039 · Cited by 113
Cellular and molecular mechanisms of HIV-1 integration targeting
Engelman, A., & Singh, P. K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2772-5 · Cited by 113
Wang, H., Jurado, K. A., Wu, X., Shun, M.-C., Li, X., Ferris, A. L., Smith, S. J., Patel, P. A., Fuchs, J. R., Cherepanov, P., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks913 · Cited by 100
Kinetics of HIV-1 capsid uncoating revealed by single-molecule analysis
Márquez, C. L., Lau, D., Walsh, J., Shah, V., McGuinness, C., Wong, A., Aggarwal, A., Parker, M. W., Jacques, D. A., Turville, S., et al. (2018) · eLife · doi:10.7554/elife.34772 · Cited by 111
Nup153 unlocks the nuclear pore complex for HIV-1 nuclear translocation in nondividing cells
Buffone, C., Martinez-Lopez, A., Fricke, T., Opp, S., Severgnini, M., Cifola, I., Petiti, L., Frabetti, S., Skorupka, K., Zadrozny, K. K., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00648-18 · Cited by 109
“We showed in a control experiment that RanBP2/Nup358 interacts with both wild-type and FIG 2 (Continued) October 2018 Volume 92 Issue 19 e00648-18 jvi.asm.org 10 mutant HIV-1 CA-NC complexes (Fig.”
BackgroundInfluentialValle-Casuso, J. C., Di Nunzio, F., Yang, Y., Reszka, N., Lienlaf, M., Arhel, N., Perez, P., Brass, A. L., & Diaz-Griffero, F. (2012) · Journal of Virology · doi:10.1128/jvi.00451-12 · Cited by 90
Retroviral Integrations in Gene Therapy Trials
Biasco, L., Baricordi, C., & Aiuti, A. (2012) · Molecular Therapy · doi:10.1038/mt.2011.289 · Cited by 106
De Iaco, A., & Luban, J. (2011) · Retrovirology · doi:10.1186/1742-4690-8-98 · Cited by 92
How host genetics dictates successful viral zoonosis
Warren, C. J., & Sawyer, S. L. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000217 · Cited by 100
Selyutina, A., Persaud, M., Simons, L. M., Bulnes-Ramos, A., Buffone, C., Martinez-Lopez, A., Scoca, V., Di Nunzio, F., Hiatt, J., Marson, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.100 · Cited by 93
Hiding in Plain Sight: How HIV Evades Innate Immune Responses
Manel, N., & Littman, D. R. (2011) · Cell · doi:10.1016/j.cell.2011.09.010 · Cited by 76
INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site Distributions
Berry, C. C., Nobles, C., Six, E., Wu, Y., Malani, N., Sherman, E., Dryga, A., Everett, J. K., Male, F., Bailey, A., et al. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2016.11.003 · Cited by 85
Self-citationInteractions between Retroviruses and the Host Cell Genome
Poletti, V., & Mavilio, F. (2017) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2017.10.001 · Cited by 93
Cyclophilins as Modulators of Viral Replication
Frausto, S., Lee, E., & Tang, H. (2013) · Viruses · doi:10.3390/v5071684 · Cited by 92
Viral Subversion of the Nuclear Pore Complex
Le Sage, V., & Mouland, A. (2013) · Viruses · doi:10.3390/v5082019 · Cited by 79
Roles of Capsid-Interacting Host Factors in Multimodal Inhibition of HIV-1 by PF74
Saito, A., Ferhadian, D., Sowd, G. A., Serrao, E., Shi, J., Halambage, U. D., Teng, S., Soto, J., Siddiqui, M. A., Engelman, A. N., et al. (2016) · Journal of Virology · doi:10.1128/jvi.03116-15 · Cited by 88
Allosteric inhibition of HIV-1 integrase activity
Engelman, A., Kessl, J. J., & Kvaratskhelia, M. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.04.010 · Cited by 75
The chromatin landscape at the HIV-1 provirus integration site determines viral expression
Vansant, G., Chen, H.-C., Zorita, E., Trejbalová, K., Miklík, D., Filion, G., & Debyser, Z. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa536 · Cited by 78
Li, X., Ewis, H. E., Hice, R. H., Malani, N., Parker, N., Zhou, L., Feschotte, C., Bushman, F. D., Atkinson, P. W., & Craig, N. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121543109 · Cited by 81
Self-citationTarget Cell-Mediated Editing of HIV-1 cDNA by APOBEC3 Proteins in Human Macrophages
Koning, F. A., Goujon, C., Bauby, H., & Malim, M. H. (2011) · Journal of Virology · doi:10.1128/jvi.00775-11 · Cited by 80
Viral Integration and Consequences on Host Gene Expression
Desfarges, S., & Ciuffi, A. (2012) · Springer eBooks · doi:10.1007/978-94-007-4899-6_7 · Cited by 80
Structural and Functional Analysis of the C-Terminal Domain of Nup358/RanBP2
Lin, D. H., Zimmermann, S., Stuwe, T., Stuwe, E., & Hoelz, A. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.01.021 · Cited by 79
Atomic-resolution structure of HIV-1 capsid tubes by magic-angle spinning NMR
Lu, M., Russell, R. W., Bryer, A. J., Quinn, C. M., Hou, G., Zhang, H., Schwieters, C. D., Perilla, J. R., Gronenborn, A. M., & Polenova, T. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0489-2 · Cited by 71
Papayannakos, C. J., & Daniel, R. (2012) · Gene Therapy · doi:10.1038/gt.2012.88 · Cited by 75
Jayappa, K. D., Ao, Z., & Yao, X. (2012) · PubMed · Cited by 72
Single-Cell Imaging of HIV-1 Provirus (SCIP)
Di Primio, C., Quercioli, V., Allouch, A., Gijsbers, R., Christ, F., Debyser, Z., Arosio, D., & Cereseto, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216254110 · Cited by 60
Demeulemeester, J., De Rijck, J., Gijsbers, R., & Debyser, Z. (2015) · BioEssays · doi:10.1002/bies.201500051 · Cited by 71
“As the viral capsid affects the mode of nuclear import, it too has been shown to modulate site selection [28, 29, 36].”
BackgroundInteraction of the HIV-1 Intasome with Transportin 3 Protein (TNPO3 or TRN-SR2)
Larue, R., Gupta, K., Wuensch, C., Shkriabai, N., Kessl, J. J., Danhart, E., Feng, L., Taltynov, O., Christ, F., Van Duyne, G. D., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.384669 · Cited by 59
Gammaretroviral Integration into Nucleosomal Target DNA In Vivo
Roth, S. L., Malani, N., & Bushman, F. D. (2011) · Journal of Virology · doi:10.1128/jvi.00635-11 · Cited by 69
Self-citationSaito, A., Henning, M. S., Serrao, E., Dubose, B. N., Teng, S., Huang, J., Li, X., Saito, N., Roy, S. P., Siddiqui, M. A., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00019-16 · Cited by 63
Dicks, M. D. J., Betancor, G., Jiménez-Guardeño, J. M., Pessel-Vivares, L., Apolonia, L., Goujon, C., & Malim, M. H. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007408 · Cited by 67
Rasheedi, S., Shun, M.-C., Serrao, E., Sowd, G. A., Qian, J., Hao, C., Dasgupta, T., Engelman, A. N., & Skowronski, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721647 · Cited by 65
“Silencing expression of any of the above proteins abolishes the characteristic pattern of preferential HIV-1 integration into active genes (3, 12, 13, 18).”
BackgroundZhou, J., Price, A. J., Halambage, U. D., James, L. C., & Aiken, C. (2015) · Journal of Virology · doi:10.1128/jvi.00340-15 · Cited by 64
Self-citationHIV Capsid Assembly, Mechanism, and Structure
Chen, B. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00159 · Cited by 64
Roles of HIV-1 capsid in viral replication and immune evasion
Sage, V. L., Mouland, A. J., & Valiente‐Echeverría, F. (2014) · Virus Research · doi:10.1016/j.virusres.2014.07.010 · Cited by 63
A Cyclophilin Homology Domain-Independent Role for Nup358 in HIV-1 Infection
Meehan, A. M., Saenz, D. T., Guevera, R., Morrison, J. H., Peretz, M., Fadel, H. J., Hamada, M., van Deursen, J., & Poeschla, E. M. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003969 · Cited by 53
HIV capsid and integration targeting
Engelman, A. N. (2021) · Viruses · doi:10.3390/v13010125 · Cited by 57
Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication
Di Nunzio, F., Fricke, T., Miccio, A., Valle-Casuso, J. C., Perez, P., Souque, P., Rizzi, E., Severgnini, M., Mavilio, F., Charneau, P., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-s1-p111 · Cited by 56
Hashizume, C., Kobayashi, A., & Wong, R. W.-C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.370 · Cited by 54
Host Factors in Retroviral Integration and the Selection of Integration Target Sites
Craigie, R., & Bushman, F. D. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0026-2014 · Cited by 45
Self-citationZhong, L., Malani, N., Li, M., Brady, T., Xie, J., Bell, P., Li, S., Jones, H., Wilson, J. M., Flotte, T. R., et al. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.112 · Cited by 49
Self-citationThe Cargo-Binding Domain of Transportin 3 Is Required for Lentivirus Nuclear Import
Logue, E. C., Taylor, K. T., Goff, P. H., & Landau, N. R. (2011) · Journal of Virology · doi:10.1128/jvi.05384-11 · Cited by 53
Ao, Z., Jayappa, K. D., Wang, B., Zheng, Y., Wang, X., Peng, J., & Yao, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.317057 · Cited by 48
Mutations affecting interaction of integrase with TNPO3 do not prevent HIV-1 cDNA nuclear import
Cribier, A., Ségéral, E., Delelis, O., Parissi, V., Simon, A., Ruff, M., Bénarous, R., & Emiliani, S. (2011) · Retrovirology · doi:10.1186/1742-4690-8-104 · Cited by 50
Imaging HIV-1 Genomic DNA from Entry through Productive Infection
Stultz, R. D., Cenker, J. J., & McDonald, D. (2017) · Journal of Virology · doi:10.1128/jvi.00034-17 · Cited by 45
Cellular and viral determinants of retroviral nuclear entry
Hamid, F. B., Kim, J., & Shin, C.-G. (2016) · Canadian Journal of Microbiology · doi:10.1139/cjm-2015-0350 · Cited by 48
Rodríguez-Mora, S., Wit, F. D., García‐Pérez, J., Bermejo, M., López‐Huertas, M. R., Mateos, E., Martí, P., Rocha, S., Vigón, L., Christ, F., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007958 · Cited by 47
Lyonnais, S., Gorelick, R. J., Heniche-Boukhalfa, F., Bouaziz, S., Parissi, V., Mouscadet, J. F., Restle, T., Gatell, J. M., Cam, É. L., & Mirambeau, G. (2012) · Virus Research · doi:10.1016/j.virusres.2012.09.008 · Cited by 46
Nunzio, F. D. (2013) · Virus Research · doi:10.1016/j.virusres.2013.09.003 · Cited by 46
A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing
Siddiqui, M. A., Saito, A., Halambage, U. D., Ferhadian, D., Fischer, D. K., Francis, A. C., Melikyan, G. B., Ambrose, Z., Aiken, C., & Yamashita, M. (2019) · Journal of Virology · doi:10.1128/jvi.00706-19 · Cited by 45
Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes
Larue, R. C., Plumb, M. R., Crowe, B. L., Shkriabai, N., Sharma, A., DiFiore, J., Malani, N., Aiyer, S. S., Roth, M. J., Bushman, F. D., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku135 · Cited by 44
Self-citationFactors that mold the nuclear landscape of HIV-1 integration
Bedwell, G. J., & Engelman, A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1207 · Cited by 44
Dahabieh, M. S., Ooms, M., Brumme, C. J., Taylor, J. M. G., Harrigan, P. R., Simon, V. R., & Sadowski, I. (2014) · Retrovirology · doi:10.1186/1742-4690-11-17 · Cited by 44
PF74 Inhibits HIV-1 Integration by Altering the Composition of the Preintegration Complex
Balasubramaniam, M., Zhou, J., Addai, A. B., Martinez, P., Pandhare, J., Aiken, C., & Dash, C. (2018) · Journal of Virology · doi:10.1128/jvi.01741-18 · Cited by 43
Metadata
- Authors
- Ocwieja, K. E., Brady, T. L., Ronen, K., Huegel, A., Roth, S. L., Schaller, T., James, L. C., Towers, G. J., Young, J. A. T., Chanda, S. K., König, R., Malani, N., Berry, C. C., & Bushman, F. D.
- Affiliations
- University of Pennsylvania (US)
- University College London (GB)
- MRC Laboratory of Molecular Biology (GB)
- Salk Institute for Biological Studies (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- University of California San Diego (US)
- Corresponding author
- Bushman, Frederic D.
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-03-10
- Volume
- 7
- Issue
- 3
- Pages
- e1001313
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3053352
- OpenAlex
- W2158419452
- Cited by
- 212
- References
- 60
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 7 · 2022: 4 · 2021: 13 · 2020: 13 · 2019: 16 · 2018: 22 · 2017: 13 · 2016: 18 · 2015: 13 · 2014: 16 · 2013: 30 · 2012: 28
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- Pennsylvania Department of Health
- Leukemia and Lymphoma Society
- University of Pennsylvania
- Wellcome Trust (WT076608, 090940)
- University College London Hospitals NHS Foundation Trust
- National Institutes of Health
- Center for AIDS Research, University of Washington
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (P01AI090935, AI52845, T32 AI-07324-17, T32AI007324, R01AI082020, R01AI052845, AI082020)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- TNPO3, RanBP2, Nup358, nucleoporins, karyopherins, HIV Gag, nuclear transport
- MeSH terms
- HIV, Humans, Virus Replication, Gene Expression Regulation, Viral, Molecular Chaperones, Nuclear Pore Complex Proteins, beta Karyopherins, RNA, Small Interfering, gag Gene Products, Human Immunodeficiency Virus, Host-Pathogen Interactions, Gene Knockdown Techniques, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.